U.S. Stem Cell, Inc. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
U.S. Stem Cell, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • U.S. Stem Cell, Inc. Return On Equity for the quarter ending December 31, 2022 was 20.4 %, a 25.5% decline year-over-year.
  • U.S. Stem Cell, Inc. annual Return On Equity for 2022 was 20.4 %, a 25.5% decline from 2021.
  • U.S. Stem Cell, Inc. annual Return On Equity for 2021 was 27.3 %, a 1.19% increase from 2020.
  • U.S. Stem Cell, Inc. annual Return On Equity for 2020 was 27 %, a 41.3% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 20.4 -6.98 -25.5% Jan 1, 2022 Dec 31, 2022
2021 27.3 +0.32 +1.19% Jan 1, 2021 Dec 31, 2021
2020 27 -19 -41.3% Jan 1, 2020 Dec 31, 2020
2019 46 +14.4 +45.6% Jan 1, 2019 Dec 31, 2019
2018 31.6 -16 -33.6% Jan 1, 2018 Dec 31, 2018
2017 47.6 +21.7 +84.2% Jan 1, 2017 Dec 31, 2017
2016 25.8 +7.82 +43.4% Jan 1, 2016 Dec 31, 2016
2015 18 -2.35 -11.5% Jan 1, 2015 Dec 31, 2015
2014 20.4 -2.41 -10.6% Jan 1, 2014 Dec 31, 2014
2013 22.8 -7.45 -24.7% Jan 1, 2013 Dec 31, 2013
2012 30.2 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.